查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840702

神经血管导管市场按产品类型、材料、尺寸、应用和最终用户划分－2025-2032年全球预测

Neurovascular Catheters Market by Product Type, Material, Size, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，神经血管导管市场规模将达到 124.5 亿美元，复合年增长率为 12.36%。

主要市场统计数据
基准年 2024 49亿美元
预计年份：2025年 55.1亿美元
预测年份：2032年 124.5亿美元
复合年增长率 (%) 12.36%

本文建构了一个框架，阐述神经血管导管在现代血管内治疗中的关键作用，以及影响这一领域的临床、技术和采购压力的汇聚。

神经血管导管在介入性神经病学、血管内治疗和急性中风治疗的交叉领域中发挥着至关重要的作用。这些导管便于进入、导航和输送脑血管内的治疗药物和植入，从而能够开展从诊断性血管造影术到复杂动脉瘤修復和血栓切除等一系列手术。近年来，微导管工程、导管尖端设计改进以及新材料的研发取得了显着进展，大大提高了导管的输送性和临床精准度，缩短了手术时间，并扩大了可治疗的病变范围。随着临床医生追求更微创的治疗方法并不断拓展适应症，导管的性能特征，例如循迹性、扭矩响应和管腔完整性，变得至关重要。

临床路径和医院系统日益围绕着针对急性神经血管事件的快速、通讯协定干预措施而构建，更加重视能够在紧急情况下快速介入并可靠运行的医疗器械。同时，器械创新、监管以及主导方主导的品质指标的整合正在重塑采购重点和供应商关係。因此，製造商和医疗系统必须在创新与可製造性、灭菌相容性和供应稳定性之间取得平衡。在这种动态环境下，对于研发、临床领导和商业营运等相关人员，精准理解产品差异化、材料权衡和营运流程要求至关重要。

该采纳为后续章节建立了一个概念框架，重点强调了技术驱动因素、临床需求和系统层面的压力，这些因素为设备设计师、医院供应负责人和政策相关人员的策略决策提供了依据。

了解影响神经血管导管设计、应用动态和供应商提案主张的关键技术、临床和监管变革。

神经血管导管领域正经历多项变革，这些变革的驱动力包括技术进步、手术流程标准化以及不断变化的医疗保险报销预期。工程师们正致力于研发兼具柔韧性和柱强度的混合结构，从而实现长距离、曲折的导管导航，同时又不影响器械输送的支撑力。同时，诸如血流导向装置和专用栓塞剂等辅助器械的普及，正在改变导管的功能需求，并催生出对差异化微导管的需求，这些微导管需针对新兴治疗方法进行优化。

临床诊疗流程正朝着规范化中风和动脉瘤管理的方向发展，优先选择能够最大限度缩短设定和更换时间的器械。这项转变促使製造商优化输送系统，以实现更快的介入、减少器械更换次数，并提升透视功能，从而实现更有效率的透视控制。法律规范也不断加强，涵盖上市后监控和产品可追溯性，鼓励企业投资于品质系统和资料收集机制，以展现产品在实际应用中的效能和安全性。在财务方面，医疗系统越来越重视手术总成本和疗效指标，这促使供应商在强调单价以外的提案主张时，更加註重器械的可靠性、降低併发症发生率以及对打包式医疗模式的支持。

总而言之，这些转变塑造了一种新的格局：衡量创新的标准不仅在于技术新颖性，更在于展现其临床和营运影响。能够将材料科学的进步与明确的临床效用和稳健的供应链结合的供应商，将更有能力影响产品应用管道和长期临床实践模式。

评估美国在2025年实施关税调整将如何改变整个供应链的筹资策略、生产地点和竞争动态。

美国2025年关税政策的调整对依赖复杂多层供应链的製造商、经销商和医院采购机构而言，曲折点。某些医疗组件进口关税的提高可能会增加医疗设备的製造成本，这些医疗器材通常包含来自全球供应商的特殊聚合物、渗透性材料和精密工程金属合金。为此，各公司正在重新审视筹资策略、生产布局和库存缓衝，以减轻关税带来的利润压力。

一些製造商可能会加快推进导管最终组装回国内的策略，或对国内战略材料供应商合格，并接受短期工具和验证方面的投资，以确保长期价格稳定。其他製造商也可能重新设计供应链，重点关注关税分类的变更，并与物流供应商重新谈判条款，以抵消不断上涨的成本。医疗系统和集团采购组织可能会向供应商施压，要求其提高成本驱动因素的透明度，并寻求合约机制来分担不断上涨的关税带来的负担，同时确保能够获得高性能设备。

除了直接的成本影响外，关税还有可能透过改变现有跨国供应商相对于本地製造商的成本地位，重塑竞争动态。这可能会促使具备互补能力的供应商进行整合，或为那些能够在不降低技术性能的前提下提供本土替代方案的灵活型公司创造利基市场机会。最终，关税的影响将取决于相关人员在成本结构变化的情况下，调整采购方式、对替代材料进行认证以及维持对品质和合规性投资的能力。

深度细分主导的洞察，揭示了产品类型、材料、尺寸、应用和最终用户环境如何相互作用，从而影响设计优先级和采用管道。

透过对产品、材料、尺寸、应用和最终用户细分进行详细分析，可以揭示临床需求与工程研发的交汇点。在产品差异化方面，诊断导管的特点在于其在血管造影术和压力监测中的作用，而引导导管则以其增强结构和柔软的尖端设计为特征，兼顾支撑性和非侵入性血管介入。微导管提供导丝引导和快速更换选项，这会影响手术流程和配套器械的兼容性。材料包括用于提高柔韧性和耐久性的聚醚嵌段酰胺、用于提高尺寸稳定性和耐热性的聚酰亚胺以及用于提高润滑性和低摩擦性的聚四氟乙烯。尺寸分级——1.2F–1.5F、1.6F–2.0F 和 2.1F–2.5F——与解剖通路范围以及可透过指定管腔输送的器械复杂程度直接相关。

动脉瘤治疗策略包括血管内卷取和血流导向装置的日益普及。栓塞术使用液体或颗粒状栓塞剂，需要配套的输送系统。门诊手术中心、医院和专科诊所各自拥有独特的采购通讯协定。即使在医院内部，社区和三级医疗机构在病例复杂程度、手术能力和临床管治也存在差异，这些差异影响着首选器械类型和供应商关係。整合这些因素凸显了器械配置、临床适应症和照护现场环境之间的相互依存关係，强调了企业需要根据不同的手术流程和医疗机构的特定要求调整产品系列。

美洲、欧洲、中东和非洲以及亚太地区之间的区域动态和战略要务的比较将影响商业化和监管方式。

区域动态对监管预期、临床实务模式和供应链物流有显着影响。在美洲，病患准入模式和以结果为基本契约推动了对具备高效性和可靠性的医疗器材的需求，而分销网络则更倾向于能够提供快速回应服务、培训和售后支援的供应商。在某些市场，复杂的报销流程和医院整合进一步影响了采购週期和大型综合医疗服务网络的议价能力。

在欧洲、中东和非洲，监管集中化和区域协调工作正在影响产品註册策略和上市后监测要求。各国临床实务和资源可用性的差异，既为提供高端产品的供应商带来了机会，也带来了挑战。在亚太地区，对三级医疗中心的快速投资、脑血管疾病盛行率的上升以及手术量的增加，正在推动先进导管技术的快速普及，但分散的采购环境和多样化的管理体制要求企业采取量身定制的市场进入策略。每个地区在临床参与、临床医生培训和经销商合作方面都存在差异，迫使製造商调整其商业化策略，以适应当地的监管时间表、临床医生的偏好和物流实际情况。

因此，采取以本地情况为依据的方法，将监管规划、本地临床证据生成和适应性经销伙伴关係相结合，对于持续推广和长期市场相关性至关重要。

对成熟的全球设备公司、敏捷的创新者和策略製造伙伴进行竞争分析，以确定商业性优势。

神经血管导管领域的竞争格局既有成熟的器材公司，也有专注于特定技术优势的专业创新企业。该领域的领导企业通常拥有多层次的产品组合，涵盖诊断、引导和微导管等器械，并将产品创新与临床医生培训和真实世界资料收集的投入相结合。这些公司强调其拥有完善的品质系统、清晰的监管管道以及全球分销和服务网络。

规模较小、专注于技术的公司通常透过材料科学的进步、专有涂层或新型製造技术来提升润滑性、抗扭结性或渗透性，从而实现差异化。关键意见领袖（KOL）的敏捷性使得公司能够快速迭代，并与卓越临床中心的关键意见领袖密切合作，从而为在特定适应症领域儘早应用产品创造机会。随着整合解决方案能够提高手术效率并减少器械更换，器械创新者与治疗性植入物和栓塞器械製造商之间的合作日益普遍。同时，契约製造製造商和组件伙伴关係也发挥关键作用，协助先进聚合物和导管尖端组件的规模化生产和成本最佳化。总而言之，竞争优势源于技术信誉、临床证据、供应可靠性以及在医疗机构采购优先事项中提出引人注目的价值主张的能力。

领导者鼓励采取切实可行的双轨倡议，以增强供应链韧性，加速具有临床意义的创新，并使商业模式与医疗机构的优先事项保持一致。

产业领导者应采取双轨策略，在短期营运韧性与持续投资临床和技术差异化之间取得平衡。目前，他们正在审查关键材料的采购和分类，以降低关税波动带来的风险，同时加快供应商资格认证计划，分散地理风险。同时，对库存管理和需求预测的同步投资将减轻供应链衝击造成的营运中断，并支持在时间紧迫的神经血管手术期间保持稳定运作。

在策略层面，我们优先进行研发工作，以解决临床医生提出的痛点，例如提高在复杂解剖结构中的操作灵活性、增强与新型植入式设备的兼容性，以及减少手术过程中更换步骤的设计。我们投资于上市后资料收集和真实世界证据的生成，以证实临床价值主张并支持医保报销谈判。我们加强与临床中心的合作，进行手术训练、基于模拟的推广计画以及迭代回馈机制，以指导产品改进。最后，我们开发将设备性能与整体手术价值（例如缩短手术时间、降低併发症发生率和提高患者吞吐量）明确挂钩的商业模式，使供应商的奖励与机构目标保持一致，并促进产品在不同终端用户环境中的应用。

采用透明、以证据主导的调查方法，结合临床医师访谈、技术评估、监管分析和供应链压力测试，为策略决策提供支援。

调查方法结合了多层次的证据框架，整合了来自临床医生、技术评估、监管分析和供应链审核的原始资讯。主要见解是透过对介入性神经科、神经介入放射科医生和采购负责人进行结构化访谈收集的，并辅以与设计工程师和材料科学家的技术咨询。二级资讯来源包括同行评审的临床文献、设备标籤标准和公开的监管文件，这些资料为设备性能和安全性方面的见解提供了背景资讯。供应链评估包括绘製材料投入、製造流程和物流节点图，以识别潜在的弱点和改进机会。

我们的分析方法融合了设备对比分析、材料性能评估以及在关税和物流中断情境下对供应链配置的压力测试。我们尽可能地对多个资料流进行三角验证，以确保研究结果的可靠性。我们将临床偏好与设计特征集进行交叉比对，并根据产品开发蓝图评估监管时间表。在整个过程中，我们始终关注潜在的偏差，并透过工程检验和临床医生的佐证检验技术声明，从而获得基于实证的实用观点，为营运决策和产品策略的优化提供支援。

整合临床、技术和营运方面的必要因素，能够为相关人员明确策略重点，帮助他们确定维持应用和降低风险的关键所在。

神经血管导管领域正经历快速的技术革新、临床通讯协定的不断变化以及复杂的供应链和法规环境。器械製造商和医疗系统都面临着双重挑战：既要为精细的神经血管介入手术提供高性能解决方案，又要维持稳健且经济高效的供应链。材料创新和精密的导管设计正在拓展手术的可能性，但要真正获得应用，必须证明其临床和操作上的优势能够引起医疗机构采购负责人和临床团队的共鸣。

关税主导的成本压力和区域监管差异要求企业积极主动地进行供应链和商业化规划，而那些整合材料策略、积极与临床医生互动并掌握本地市场情报的企业将更有能力应对不确定性。透过将产品开发与临床医生提出的需求结合、投资于真实世界证据并建立灵活的采购模式，相关人员可以加速产品推广应用并降低系统性风险。因此，专注于技术卓越、务实执行以及可衡量的临床和营运成果的这一领域将获得回报。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 开发生物活性聚合物涂层以减少神经血管导管中的血栓形成
  • 低剖面神经血管导管可改善远端脑血管的路径。
  • 将机器人技术和人工智慧驱动的引导系统结合，用于神经介入手术中的精准导管置入
  • 新型双腔导管设计可在中风治疗中同时进行抽吸和支架取出。
  • 增加药物释放型技术的投资，以预防颅内支架辅助弹簧圈栓塞术后的再血管再阻塞
  • 重点研发渗透性标记物，以提高神经血管手术中导管尖端的可见性
  • 神经介入手术室改用一次性无菌包装解决方案，以最大限度降低感染风险
  • 经经皮神经血管通路技术的推广应用可缩短患者復原时间和住院时间。
  • 监管核准趋势对下一代神经血管导管器械市场准入的影响
  • 医疗器材製造商与医疗服务提供者合作，优化导管材料的生物相容性

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 神经血管导管市场（依产品类型划分）

  • 诊断导管
    • 血管造影术诊断
    • 压力监测
  • 引导管
    • 加强
    • 软头
  • 微导管
    • 附导线
    • 快速交换

9. 按材料分類的神经血管导管市场

  • 聚醚嵌段酰胺
  • 聚酰亚胺
  • 聚四氟乙烯

第十章 神经血管导管市场（依尺寸划分）

  • 1.2F～1.5F
  • 1.6F～2.0F
  • 2.1F～2.5F

第十一章 神经血管导管市场（依应用领域划分）

  • 动脉瘤治疗
    • 血管内弹簧圈栓塞术
    • 分流装置
  • 栓塞术
    • 液体栓塞
    • 颗粒栓塞
  • 血栓切除术

第十二章 神经血管导管市场（依最终用户划分）

  • 门诊手术中心
  • 医院
    • 社群
    • 三级医疗
  • 专科诊所

第十三章 神经血管导管市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 神经血管导管市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国神经血管导管市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Stryker Corporation
    • Johnson & Johnson Services, Inc.
    • Boston Scientific Corporation
    • Penumbra, Inc.
    • Terumo Corporation
    • MicroVention, Inc.
    • Merit Medical Systems, Inc.
    • Becton, Dickinson and Company
    • WL Gore & Associates, Inc.
Product Code: MRR-A339DAEF9DC3

The Neurovascular Catheters Market is projected to grow by USD 12.45 billion at a CAGR of 12.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.90 billion
Estimated Year [2025] USD 5.51 billion
Forecast Year [2032] USD 12.45 billion
CAGR (%) 12.36%

Framing the critical role of neurovascular catheters in modern endovascular care and the converging clinical, technological, and procurement pressures shaping the field

Neurovascular catheters occupy a pivotal role at the intersection of interventional neurology, endovascular therapy, and acute stroke care. These devices facilitate access, navigation, and delivery of therapeutic agents or implants within cerebral vasculature, enabling procedures ranging from diagnostic angiography to complex aneurysm repair and thrombectomy. Recent advances in microcatheter engineering, refined catheter tip designs, and novel materials have collectively improved deliverability and clinical precision, reducing procedural time and expanding the treatable lesion set. As clinicians push toward less invasive approaches and expanded indications, the importance of catheter performance attributes such as trackability, torque response, and lumen integrity has become paramount.

Clinical pathways and hospital systems are increasingly structured around rapid, protocol-driven interventions for acute neurovascular events, which places greater emphasis on devices that support swift access and reliable performance under emergency conditions. At the same time, the convergence of device innovation, regulatory scrutiny, and payer-driven quality metrics reshapes procurement priorities and vendor relationships. Consequently, manufacturers and health systems must balance technical innovation with manufacturability, sterilization compatibility, and supply resilience. In this dynamic environment, a precise understanding of product differentiation, material trade-offs, and procedural requirements is essential for stakeholders across research and development, clinical leadership, and commercial operations.

This introduction establishes the conceptual frame for subsequent sections by highlighting the technological drivers, clinical imperatives, and system-level pressures that will inform strategic decisions for device designers, hospital supply leaders, and policy stakeholders.

Understanding the pivotal technological, clinical, and regulatory transformations reshaping neurovascular catheter design, adoption dynamics, and supplier value propositions

The neurovascular device landscape is experiencing several transformative shifts driven by technological refinement, procedural standardization, and evolving reimbursement expectations. Engineers are focusing on hybrid constructions that combine flexibility with column strength, enabling long, tortuous navigations without sacrificing support for device delivery. Concurrently, the proliferation of adjunctive devices-such as flow diverters and specialized embolic agents-has altered catheter function requirements, creating demand for differentiated microcatheters optimized for compatibility with emerging therapies.

Clinical pathways are trending toward protocolization of stroke and aneurysm responses, which prioritizes devices that minimize setup and exchange time. This shift incentivizes manufacturers to optimize delivery systems for rapid access, reduce device exchanges, and enhance radiopacity for more efficient fluoroscopic control. Regulatory frameworks are also tightening around post-market surveillance and product traceability, prompting firms to invest in quality systems and data capture mechanisms that demonstrate real-world performance and safety. Financially, health systems are increasingly evaluating total procedural cost and outcome metrics, which encourages vendors to articulate value propositions that go beyond unit price to include device reliability, reduced complication rates, and support for bundled care models.

Taken together, these shifts create a landscape in which innovation is measured not only in technical novelty but also in demonstrable clinical and operational impact. Vendors that can integrate materials science advances with clear clinical utility and supply chain robustness will be best positioned to influence adoption pathways and long-term clinical practice patterns.

Assessing how the introduction of United States tariff adjustments in 2025 will alter sourcing strategies, production footprints, and competitive dynamics across the supply chain

Tariff policy changes in the United States for 2025 present an inflection point for manufacturers, distributors, and hospital purchasing organizations that rely on complex, multi-tiered supply chains. Increased import duties on certain medical components can elevate production costs for devices that incorporate specialized polymers, radiopaque materials, or precision-engineered metal alloys sourced from global suppliers. In response, organizations will reassess sourcing strategies, production footprints, and inventory buffers to mitigate exposure to tariff-driven margin pressure.

Some manufacturers may accelerate strategies to onshore the final assembly of catheters or to qualify domestic suppliers for strategic materials, accepting short-term investment in tooling and validation to secure longer-term pricing stability. Others may pursue tariff classification reviews and supply chain redesigns that emphasize consolidation of shipments and renegotiation of commercial terms with logistics providers to offset cost increases. Health systems and group purchasing organizations will likely pressure vendors for greater transparency on cost drivers and pursue contract mechanisms that share the burden of incremental duties while preserving access to high-performance devices.

Beyond direct cost implications, tariff measures can reshape competitive dynamics by altering the relative cost positions of established multinational suppliers versus regionally based manufacturers. This may spur consolidation among suppliers with complementary capabilities, or create niche opportunities for agile firms that can provide onshore alternatives without compromising on technical performance. Ultimately, tariff effects will be mediated by the capacity of stakeholders to adapt procurement practices, qualify alternative materials, and sustain investments in quality and regulatory compliance amid shifting cost structures.

Deep segmentation-driven insights revealing how product type, materials, sizes, applications, and end-user settings interact to shape design priorities and adoption pathways

A granular view of product, material, size, application, and end-user segmentation illuminates where clinical demand and engineering effort converge. When considering product distinctions, diagnostic catheters are characterized by roles in angiographic imaging and pressure monitoring; guiding catheters are differentiated by reinforced constructions and soft-tip designs that balance support and atraumatic vessel engagement; and microcatheters present choices between over-the-wire systems and rapid exchange formats that influence procedural workflow and companion device compatibility. Material selection plays a central role in device behavior, with polyether block amide offerings prized for flexibility and durability, polyimide used where dimensional stability and heat resistance are required, and polytetrafluoroethylene selected for its lubricity and low friction. Size gradations ranging from 1.2F to 1.5F, 1.6F to 2.0F, and 2.1F to 2.5F correlate directly with the scope of anatomical access and the complexity of devices that can be delivered through a given lumen.

Application-based segmentation further clarifies clinical trajectories: aneurysm treatment strategies encompass endovascular coiling and the growing use of flow diversion devices, embolization procedures may employ liquid or particle embolic agents requiring compatible delivery systems, and thrombectomy tools demand catheters capable of efficient clot engagement and aspiration. The distribution of procedural volume across end users influences product development and commercialization strategies, with ambulatory surgery centers, hospitals, and specialty clinics each presenting distinctive purchasing protocols. Within hospitals, community and tertiary care facilities diverge in case complexity, procedural throughput, and clinical governance, shaping preferred device profiles and supplier relationships. Synthesizing these segmentations highlights the interdependence between device configuration, clinical indication, and point-of-care environment, and underscores the imperative for companies to align product portfolios with nuanced procedural and institutional requirements.

Comparative regional dynamics and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that dictate commercialization and regulatory approaches

Regional dynamics exert a substantial influence on regulatory expectations, clinical practice patterns, and supply chain logistics. In the Americas, patient access models and an emphasis on outcomes-based contracting are driving demand for devices that demonstrate procedural efficiency and reliability, while distribution networks favor vendors that can provide rapid service, training, and post-market support. Reimbursement complexity and hospital consolidation in some markets further shape purchasing timelines and the negotiation leverage of large integrated delivery networks.

Within Europe, the Middle East & Africa, regulatory alignment driven by centralized authorities and regional harmonization efforts impacts product registration strategies and post-market surveillance requirements. Clinical practice variability across countries and variable resource availability create both opportunities and constraints for vendors offering premium designs. In Asia-Pacific, rapid investment in tertiary care centers, growing prevalence of cerebrovascular disease, and increasing procedural volumes are motivating faster adoption of advanced catheter technologies, though fragmented procurement environments and diverse regulatory regimes require tailored market entry approaches. Each region presents distinct paths for clinical engagement, clinician training, and distributor partnerships, and manufacturers must calibrate commercialization strategies that reflect local regulatory timelines, clinician preferences, and logistical realities.

Consequently, a regionally informed approach that integrates regulatory planning, local clinical evidence generation, and adaptive distribution partnerships will be essential for sustained adoption and long-term market relevance.

Analyzing competitive strengths across established global device companies, agile innovators, and strategic manufacturing partners that determine commercial advantage

Competitive landscapes in neurovascular catheters are shaped by a mixture of established device firms and specialized innovators focusing on narrow technical advantages. Leaders in the space typically maintain multi-tiered portfolios that span diagnostic, guiding, and microcatheter offerings and that pair product innovation with investments in clinician training and real-world data collection. These companies emphasize robust quality systems, clear regulatory pathways, and the capacity to support global distribution and service networks.

Smaller, technology-focused firms often differentiate by advancing materials science, proprietary coatings, or novel manufacturing techniques that improve lubricity, kink resistance, or radiopacity. Their agility allows for rapid iteration and close collaboration with key opinion leaders in clinical centers of excellence, creating early adoption opportunities for niche indications. Partnerships between device innovators and makers of therapeutic implants or embolic agents are increasingly common, as integrated solutions enhance procedural efficiency and reduce device exchanges. In parallel, contract manufacturers and component specialists play critical roles by enabling scale-up and cost optimization for advanced polymer and catheter tip assemblies. Overall, competitive advantage stems from a combination of technical credibility, clinical evidence, supply reliability, and the ability to present compelling value in the context of institutional procurement priorities.

Practical, dual-track recommendations for leaders to strengthen supply resilience, accelerate clinically meaningful innovation, and align commercial models with institutional priorities

Industry leaders should adopt a dual-track strategy that balances near-term operational resilience with sustained investment in clinical and technological differentiation. In the immediate term, reassess sourcing and classification of critical materials to blunt exposure to tariff volatility while accelerating supplier qualification programs that diversify geographic risk. Parallel investments in inventory management and demand sensing will reduce the operational disruption from supply chain shocks and support consistent availability in time-sensitive neurovascular procedures.

Strategically, prioritize R&D that addresses clinician-identified pain points such as improved navigability in tortuous anatomies, compatibility with new implantable devices, and designs that reduce exchange steps during procedures. Invest in post-market data capture and real-world evidence generation to substantiate claims of clinical value and to support reimbursement dialogues. Strengthen collaborations with clinical centers for procedural training, simulation-based adoption programs, and iterative feedback loops that inform product refinement. Finally, build commercial models that articulate total procedural value-linking device performance to reduced procedure time, lower complication rates, and improved patient throughput-to align vendor incentives with institutional goals and accelerate uptake across diverse end-user settings.

Transparent and evidence-driven research methodology combining clinician interviews, technical evaluations, regulatory analysis, and supply chain stress-testing to support strategic decisions

The research approach combined a multi-tiered evidence framework that synthesizes primary clinician inputs, engineering assessments, regulatory analysis, and supply chain audits. Primary insights were gathered through structured interviews with interventional neurologists, neurointerventional radiologists, and procurement leaders, supplemented by technical consultations with design engineers and materials scientists. Secondary sources encompassed peer-reviewed clinical literature, device labeling standards, and publicly accessible regulatory filings, which informed device performance context and safety considerations. Supply chain assessments included mapping of material inputs, manufacturing steps, and logistics nodes to identify potential vulnerability points and resilience opportunities.

Analytical methods incorporated comparative device profiling, materials property evaluation, and scenario-based stress testing of supply chain configurations under tariff and logistical disruption scenarios. Where possible, triangulation across data streams ensured robustness of findings: clinical preferences were cross-referenced with design feature sets, and regulatory timelines were evaluated against product development roadmaps. Throughout the process, attention was paid to potential bias and to the validation of technical claims through engineering verification and clinician corroboration, yielding a pragmatic and evidence-grounded perspective that supports operational decision-making and product strategy refinement.

Synthesis of clinical, technical, and operational imperatives that conclude with strategic clarity on where stakeholders must focus to sustain adoption and reduce risk

The neurovascular catheter landscape is defined by rapid technical evolution, shifting clinical protocols, and an increasingly complex supply and regulatory environment. Device makers and health systems alike face the dual imperatives of delivering high-performance solutions for delicate cerebrovascular interventions while maintaining resilient, cost-effective supply chains. Material innovations and refined catheter architectures are expanding procedural capabilities, yet adoption hinges on demonstrable clinical benefits and operational advantages that resonate with institutional purchasers and clinical teams.

Tariff-driven cost pressures and regional regulatory subtleties demand proactive supply chain and commercialization planning, and companies that integrate materials strategy, clinician collaboration, and regional market intelligence will be best positioned to navigate uncertainty. By aligning product development with clinician-identified needs, investing in real-world evidence, and building flexible sourcing models, stakeholders can both accelerate adoption and reduce systemic risk. The combined result is a field that rewards technical excellence paired with pragmatic execution and an orientation toward measurable clinical and operational outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of bioactive polymer coatings to reduce thrombogenicity in neurovascular catheters
  • 5.2. Adoption of low-profile neurovascular catheters to improve access in distal cerebral vasculature
  • 5.3. Integration of robotics and AI-driven guidance systems for precise catheter placement in neurointerventions
  • 5.4. Emergence of dual-lumen catheter designs enabling simultaneous aspiration and stent retrieval in stroke treatment
  • 5.5. Growing investment in drug-eluting technologies to prevent restenosis after intracranial stent-assisted coiling
  • 5.6. Focus on developing radiopaque markers for enhanced visualization of catheter tip during neurovascular procedures
  • 5.7. Shift towards single-use sterile packaging solutions to minimize infection risk in neurointerventional suites
  • 5.8. Expansion of percutaneous neurovascular access techniques reducing patient recovery times and hospital stays
  • 5.9. Regulatory approval trends influencing market entry of next-generation neurovascular catheter devices
  • 5.10. Collaborations between device manufacturers and healthcare providers to optimize catheter material biocompatibility

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurovascular Catheters Market, by Product Type

  • 8.1. Diagnostic Catheters
    • 8.1.1. Angiographic Diagnostic
    • 8.1.2. Pressure Monitoring
  • 8.2. Guiding Catheters
    • 8.2.1. Reinforced
    • 8.2.2. Soft Tip
  • 8.3. Microcatheters
    • 8.3.1. Over The Wire
    • 8.3.2. Rapid Exchange

9. Neurovascular Catheters Market, by Material

  • 9.1. Polyether Block Amide
  • 9.2. Polyimide
  • 9.3. Polytetrafluoroethylene

10. Neurovascular Catheters Market, by Size

  • 10.1. 1.2F To 1.5F
  • 10.2. 1.6F To 2.0F
  • 10.3. 2.1F To 2.5F

11. Neurovascular Catheters Market, by Application

  • 11.1. Aneurysm Treatment
    • 11.1.1. Endovascular Coiling
    • 11.1.2. Flow Diversion Devices
  • 11.2. Embolization Procedures
    • 11.2.1. Liquid Embolization
    • 11.2.2. Particle Embolization
  • 11.3. Thrombectomy

12. Neurovascular Catheters Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Hospitals
    • 12.2.1. Community
    • 12.2.2. Tertiary Care
  • 12.3. Specialty Clinics

13. Neurovascular Catheters Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Neurovascular Catheters Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Neurovascular Catheters Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtronic plc
    • 16.3.2. Stryker Corporation
    • 16.3.3. Johnson & Johnson Services, Inc.
    • 16.3.4. Boston Scientific Corporation
    • 16.3.5. Penumbra, Inc.
    • 16.3.6. Terumo Corporation
    • 16.3.7. MicroVention, Inc.
    • 16.3.8. Merit Medical Systems, Inc.
    • 16.3.9. Becton, Dickinson and Company
    • 16.3.10. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR CATHETERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE NEUROVASCULAR CATHET